medRxiv : the preprint server for health sciences · 2025
Accuracy of electronic medical records to quantify rates of sedative and analgesic infusions for acute disorders of consciousness big data research.
СтатьяПрепринтНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Briard Joel Neves, Kansara Vedant, Dumitru Roxana, Shen Qi, Patel Sweta, Song You Lim, Rao Samvrit Vasudev, Klein Alex J, Vancura Bert, Velazquez Angela, Ghoshal Shivani, Roh David, Agarwal Sachin, Park Soojin, Connolly E Sander, Claassen Jan
Аннотация
BACKGROUND/OBJECTIVE: The reliability of electronic medical records (EMR) for exposure to sedative and analgesic medications in patients with acute disorders of consciousness is unknown. Our objective was to quantify the accuracy of sedative and analgesic infusion rates derived from the EMR to support its use in big data clinical research.
METHODS: We conducted a prospective cohort study enrolling critically ill patients who were unresponsive to verbal commands after acute brain injury. During standardized behavioral assessments, research coordinators documented infusing sedative and analgesic medications in case report forms (CRF; reference standard). We extracted infusion rates from the EMR (index) and calculated concordance correlation coefficients for drugs with ≥ 10 EMR-CRF infusion rate pairs.
RESULTS: Among 63 included patients (median age: 61 [46-72]; 22 [35%] female), we collected 404 pairs (225 fentanyl, 86 propofol, 70 dexmedetomidine, 19 midazolam, 4 ketamine). Correlation coefficients were 0.82 (95% CI: 0.69-0.91) for propofol, 0.93 (95% CI: 0.85-0.97) for fentanyl, 0.92 (95% CI: 0.81-0.98) for dexmedetomidine and 0.94 (95% CI: 0.55-1.00) for midazolam.
CONCLUSIONS: EMR derived data on sedative and analgesic infusion rates has variable but overall adequate accuracy to support big data research. External validation is required to support its routine use in clinical research.
METHODS: We conducted a prospective cohort study enrolling critically ill patients who were unresponsive to verbal commands after acute brain injury. During standardized behavioral assessments, research coordinators documented infusing sedative and analgesic medications in case report forms (CRF; reference standard). We extracted infusion rates from the EMR (index) and calculated concordance correlation coefficients for drugs with ≥ 10 EMR-CRF infusion rate pairs.
RESULTS: Among 63 included patients (median age: 61 [46-72]; 22 [35%] female), we collected 404 pairs (225 fentanyl, 86 propofol, 70 dexmedetomidine, 19 midazolam, 4 ketamine). Correlation coefficients were 0.82 (95% CI: 0.69-0.91) for propofol, 0.93 (95% CI: 0.85-0.97) for fentanyl, 0.92 (95% CI: 0.81-0.98) for dexmedetomidine and 0.94 (95% CI: 0.55-1.00) for midazolam.
CONCLUSIONS: EMR derived data on sedative and analgesic infusion rates has variable but overall adequate accuracy to support big data research. External validation is required to support its routine use in clinical research.